The Academy's evidence-based guidelines are published in the Journal of the American Academy of Dermatology (JAAD) and are considered current for five years from the date of publication unless superseded by an update. These guidelines also are submitted to the National Guideline Clearinghouse.

Previously published evidence-based guidelines that have been sunset or updated may be viewed in the guideline archive.

Clinical resource tools such as PowerPoint slide sets and physician or patient summaries are under development for certain guidelines to facilitate wider dissemination of guideline recommendations, to foster implementation, and assist in physician-patient/caregiver interactions.

If you need additional information about AAD guidelines, email your query to guidelines@aad.org.

DISCLAIMER

Adherence to these guidelines will not ensure successful treatment in every situation. Furthermore, these guidelines should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific therapy must be made by the physician and the patient in light of all the circumstances presented by the individual patient, and the known variability and biological behavior of the disease. This guideline reflects the best available data at the time the guideline was prepared. The results of future studies may require revisions to the recommendations in this guideline to reflect new data.

Current approved and published guidelines

Evidence-based guidelines in development

The Academy is continually working to develop new evidence-based guidelines to support our members. Below are the board-approved guideline topics that are in development. The status of each topic will be updated as work progresses.